Profile photo Thomas van Sloten

Thomas van Sloten

Assistant Professor - medical

Strategic program(s):

Biography

Dr Thomas van Sloten works as an clinical-scientist (Assistant Professor) at the Department of Vascular Medicine of University Medical Centre Utrecht, the Netherlands. He studied Medicine at Maastricht University and Clinical Epidemiology at VU University Amsterdam, both in the Netherlands. He did his PhD research at the Department of Internal Medicine of Maastricht University Medical Centre, Maastricht, the Netherlands. Thomas also worked at the National Institutes of Health (USA) and at INSERM U970, Paris Cardiovascular Research Center (France). 

The focus of his research is the epidemiological study of the role of vascular dysfunction in the development brain diseases that are common among individuals with diabetes, including stroke, dementia and depression. A key element of his research is that he combines multiple research domains, including epidemiology, endocrinology, physiology, neuropsychiatry and neuroimaging science. He has also always combined research with clinical work. Thomas has been awarded with various grants, including a Veni grant (Dutch Research Council NWO talent scheme), a Dekker clinical scientist grant (Dutch Heart Foundation) and a Diabetes Fonds Fellowship (Dutch Diabetes Research Foundation). His scientific work has been published in leading journals in the field, such as Lancet Diabetes & Endocrinology and JAMA. 

Recent publications

Microvascular Dysfunction and Whole-Brain White Matter Connectivity Magdalena Beran, April C E van Gennip, Coen D A Stehouwer, Jacobus F A Jansen, Monideepa D Gupta, Alfons J H M Houben, Tos T J M Berendschot, Carroll A B Webers, Anke Wesselius, Casper G Schalkwijk, Walter H Backes, Joost J A de Jong, Carla J H van der Kallen, Marleen M J van Greevenbroek, Sebastian Köhler, Jet M J Vonk, Mirjam I Geerlings, Miranda T Schram, Thomas T van Sloten
Journal of the American Heart Association, 2024, vol. 13
The association of sociodemographic factors with total and item-level semantic fluency metrics Magdalena Beran, Emma L Twait, Annelot P Smit, Marleen F Posthuma, Demi van Dijk, Katherinne M Rabanal, Dayanara Rosado, Roxanna J Flores, Carolyn L Qian, Shana S Samuel, Gelan Ying, Richard Mayeux, Thomas T van Sloten, Miranda T Schram, Jennifer J Manly, Mirjam I Geerlings, Jet M J Vonk
Neuropsychology, 2024, vol. 38, p.665-678
Variability in benefit from intensive insulin therapy on cardiovascular events in individuals with type 1 diabetes Marga A.G. Helmink, Steven H.J. Hageman, Frank L.J. Visseren, Wendela L. de Ranitz-Greven, Harold W. de Valk, Thomas T. van Sloten, Jan Westerink
Diabetic Medicine, 2023, vol. 40, p.1-10
Associations of plasma NfL, GFAP, and t-tau with cerebral small vessel disease and incident dementia April C E van Gennip, Claudia L Satizabal, Russell P Tracy, Sigurdur Sigurdsson, Vilmundur Gudnason, Lenore J Launer, Thomas T van Sloten
GeroScience, 2023, vol. 46, p.505-516
Long-term lifestyle change and risk of mortality and type 2 diabetes in patients with cardiovascular disease Nadia E Bonekamp, Frank L J Visseren, Maarten J Cramer, Jannick A N Dorresteijn, Manon G van der Meer, Y M Ruigrok, Thomas T van Sloten, Martin Teraa, Johanna M Geleijnse, Charlotte Koopal
European journal of preventive cardiology, 2023, vol. 31, p.205-213
Association of Midlife Cardiovascular Health and Subsequent Change in Cardiovascular Health With Incident Cancer Thomas Van Sloten, Eugénie Valentin, Rachel E Climie, Omar Deraz, Elisabete Weiderpass, Xavier Jouven, Marcel Goldberg, Marie Zins, Jean-Philippe Empana
J AM Coll Cardiol CardioOnc, 2023, vol. 5, p.39-52